Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|April 11, 2020
Peripheral Blood Lymphocyte Phenotype Differentiates Secondary Antibody Deficiency in Rheumatic Disease from Primary Antibody DeficiencyAlexandra Jablonka, Haress Etemadi, Ignatius Ryan Adriawan, et al.
International Archives of Allergy and Immunology|October 7, 2021
Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary ImmunodeficiencyGeorgios Sogkas, Natalia Dubrowinskaja, Katharina Schütz, et al.
Frontiers in Cardiovascular Medicine|January 9, 2019
Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More?Diana Ernst, Christian Widera, Desiree Weiberg, et al.
Annals of the Rheumatic Diseases|September 29, 2021
Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritisIgnatius Ryan Adriawan, Faranaz Atschekzei, Oliver Dittrich-Breiholz, et al.
Frontiers in Medicine|August 9, 2020
Lung Involvement in Primary Sjögren's Syndrome-An Under-Diagnosed EntityGeorgios Sogkas, Stefanie Hirsch, Karen Maria Olsson, et al.
Frontiers in Immunology|December 6, 2019
Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1Claudia Schröder, Georgios Sogkas, Manfred Fliegauf, et al.
Diseases (Basel, Switzerland)|April 17, 2019
Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2)Georgios Sogkas, Natalia Dubrowinskaja, Anke K Bergmann, et al.
Frontiers in Immunology|March 7, 2022
Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic FactorsLuzia Bruns, Victoria Panagiota, Sandra von Hardenberg, et al.
International Journal of Environmental Research and Public Health|June 16, 2018
Tuberculosis Specific Interferon-Gamma Production in a Current Refugee Cohort in Western EuropeAlexandra Jablonka, Christian Dopfer, Christine Happle, et al.
Frontiers in Immunology|September 9, 2024
JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature reviewFaranaz Atschekzei, Stephan Traidl, Julia Carlens, et al.
Pageof 6